GSTP1 and mesothelioma: Chen et al. found that the ROS/JNK pathway was mainly involved in the sensitization of mesothelioma cells to cisplatin upon GSTP1 knockdown, whereas the pathway seemed to be irrelevant for the effect of GSTP1 silencing on cell sensitivity to oxaliplatin [65].